{"id":"W2617889858","doi":"10.1016/j.breast.2017.05.004","title":"Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Trastuzumab; Tolerability; Discontinuation; Adverse effect; Cohort; Internal medicine; Adjuvant; Syringe; Oncology; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001284061,0.0001641315,0.0003125894,0.00001932624,0.0008759196,0.0001963118,0.0006313812,0.0001006405,0.00009179772],"category_scores_gemma":[0.0004882251,0.00008420003,0.00006919917,0.00004448175,0.0002999861,0.00005976076,0.0002378028,0.0006491692,0.00005952265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001126454,"about_ca_system_score_gemma":0.0002048793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004863419,"about_ca_topic_score_gemma":0.0003274016,"domain_scores_codex":[0.9983098,0.0001899898,0.0002905132,0.0003280347,0.0005040523,0.0003776271],"domain_scores_gemma":[0.9973753,0.0008765547,0.0001519933,0.001387112,0.00005293125,0.000156082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1034039,0.0001274623,0.008812403,0.00003188979,0.000412679,0.0002527735,0.006319875,0.000002478048,0.001085973,0.0001040432,0.004048715,0.8753978],"study_design_scores_gemma":[0.0543518,0.0013956,0.9169766,0.0004973406,0.000427158,0.00157655,0.0006180007,0.0001616656,0.0003421908,0.001636903,0.0216689,0.000347292],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9597901,0.0001792633,0.00004102446,0.02699087,0.0002535593,0.001092901,0.0004412349,0.00004915545,0.01116192],"genre_scores_gemma":[0.9958018,0.00008873022,0.00004563097,0.0001670175,0.002871848,0.00001568513,0.00002700882,0.00003517716,0.0009471136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9081642,"threshold_uncertainty_score":0.7352067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05830078814096429,"score_gpt":0.3442258103662161,"score_spread":0.2859250222252518,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}